Literature DB >> 12090476

FHIT protein expression and its relation to apoptosis, tumor histologic grade and prognosis in colorectal adenocarcinoma: an immunohistochemical and image analysis study.

Hussam H Mady1, Mona F Melhem.   

Abstract

The FHIT gene, a member of the histidine triad family has been identified as a tumor suppressor gene. Molecular genetic approaches to determine alterations in the FHIT gene in colorectal cancers have produced varying results with reported abnormalities of the FHIT gene transcripts in 13% to 50% of cases studied. FHIT has been reported to be involved in the regulation of apoptosis and cell cycle in cell culture systems. Immunohistochemical (IHC) studies of FHIT expression in human colon cancer and its correlation to apoptosis and clinical prognosis have been sparse. We studied 100 human colorectal cancers by IHC and a computerized image analysis (CIA) method to evaluate FHIT expression and the rate of apoptosis in tumors and corresponding mucosae. Follow-up data for at least five years was available for all patients. We correlated the results with tumor grade, stage and clinical prognosis. We used commercially available polyclonal anti FHIT antibody and Apoptaq kit on paraffin-embedded tumors and their corresponding mucosae and the SAMBA 4000 CIA system to evaluate the labeling index (LI), the mean optical density (MOD) of the stain and calculate a quick score (QS). The LI is the ratio of positively stained areas to the total area of the tissues examined, the MOD represents the concentration of the positive stain as measured per positive pixels and the QS a numeric product of the LI and MOD for each microscopic area examined. Image analysis of IHC staining of the tumor sections defined three main groups based on the reactivity of the anti FHIT polyclonal antibody. Group I included 23 cases where the LI was less than 55% with a mean of 36%. Eight cases in this group showed complete loss of FHIT expression. Group II included 41 cases where the LI was between 55% and 65% with a mean of 60%. Group III was composed of 36 cases where the LI was more than 65% with a mean of 69%. Our data showed that the absence or reduction of FHIT protein in the tumors, relative to morphologically normal mucosa, plays a role in the development of a few colorectal cancers (23%). Poorly differentiated carcinomas showed absent or decreased FHIT. A reduction of FHIT was positively correlated with the rate of distant metastases and worse prognosis. Over-expression of FHIT is directly proportional to the apoptotic rate in the tumors examined. CIA provides an objective and accurate assessment of the staining patterns and generates numerical data evaluating intensity better than depending on subjective light microscopy alone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12090476     DOI: 10.1023/a:1015594702522

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  25 in total

1.  Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions.

Authors:  X P Hao; J E Willis; T G Pretlow; J S Rao; G T MacLennan; I C Talbot; T P Pretlow
Journal:  Cancer Res       Date:  2000-01-01       Impact factor: 12.701

2.  Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines.

Authors:  B Simon; D Bartsch; P Barth; N Prasnikar; K Münch; A Blum; R Arnold; B Göke
Journal:  Cancer Res       Date:  1998-04-15       Impact factor: 12.701

Review 3.  Cell death by apoptosis in epidermal biology.

Authors:  A R Haake; R R Polakowska
Journal:  J Invest Dermatol       Date:  1993-08       Impact factor: 8.551

4.  The FHIT gene at 3p14.2 is abnormal in breast carcinomas.

Authors:  M Negrini; C Monaco; I Vorechovsky; M Ohta; T Druck; R Baffa; K Huebner; C M Croce
Journal:  Cancer Res       Date:  1996-07-15       Impact factor: 12.701

5.  Role of FHIT in human cancer.

Authors:  C M Croce; G Sozzi; K Huebner
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

6.  Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.

Authors:  D L Greenspan; D C Connolly; R Wu; R Y Lei; J T Vogelstein; Y T Kim; J E Mok; N Muñoz; F X Bosch; K Shah; K R Cho
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

7.  Absence of Msh2 protein expression is associated with alteration in the FHIT locus and Fhit protein expression in colorectal carcinoma.

Authors:  M Mori; K Mimori; T Masuda; K Yoshinaga; K Yamashita; A Matsuyama; H Inoue
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

8.  Inhibition of apoptosis during development of colorectal cancer.

Authors:  A Bedi; P J Pasricha; A J Akhtar; J P Barber; G C Bedi; F M Giardiello; B A Zehnbauer; S R Hamilton; R J Jones
Journal:  Cancer Res       Date:  1995-05-01       Impact factor: 12.701

9.  Increased apoptosis accompanies neoplastic development in the human colorectum.

Authors:  F A Sinicrope; G Roddey; T J McDonnell; Y Shen; K R Cleary; L C Stephens
Journal:  Clin Cancer Res       Date:  1996-12       Impact factor: 12.531

Review 10.  Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.

Authors:  J F Kerr; A H Wyllie; A R Currie
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

View more
  11 in total

1.  Loss of fragile histidine triad protein expression in inflammatory bowel disease.

Authors:  Chun-Mei Xu; Chuan-Hu Qiao
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

2.  Usefulness of plasma epigenetic changes of five major genes involved in the pathogenesis of colorectal cancer.

Authors:  Seung-Chul Pack; Hye-Ran Kim; Sang-Woo Lim; Hwan-Young Kim; Jung-Yun Ko; Ki-Sang Lee; David Hwang; Seong-Il Park; Hoon Kang; Sang-Wook Park; Gun-Young Hong; Se-Min Hwang; Myung-Geun Shin; Soong Lee
Journal:  Int J Colorectal Dis       Date:  2012-09-19       Impact factor: 2.571

3.  Higher expression of phosphorylated myosin regulatory light chain in the common bile duct in pancreaticobiliary maljunction accompanied by bile duct dilatation in children: a post-mortem observational study.

Authors:  Wan-liang Guo; Qi Zhang; Jian Wang; Mei-fang Jin
Journal:  Pediatr Surg Int       Date:  2012-12-09       Impact factor: 1.827

4.  The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions.

Authors:  G Terry; L Ho; P Londesborough; C Duggan; A Hanby; J Cuzick
Journal:  Br J Cancer       Date:  2006-12-12       Impact factor: 7.640

5.  Anti-carcinogenic effects of the phenolic-rich extract from abnormal Savda Munziq in association with its cytotoxicity, apoptosis-inducing properties and telomerase activity in human cervical cancer cells (SiHa).

Authors:  Guzalnur Abliz; Fatima Mijit; Li Hua; Guzalnur Abdixkur; Tangnur Ablimit; Nurmuhammat Amat; Halmurat Upur
Journal:  BMC Complement Altern Med       Date:  2015-02-12       Impact factor: 3.659

6.  A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.

Authors:  Michelle E Penney; Patrick S Parfrey; Sevtap Savas; Yildiz E Yilmaz
Journal:  BMC Cancer       Date:  2019-02-09       Impact factor: 4.430

7.  Cancer and the FRA3B/FHIT fragile locus: it's a HIT.

Authors:  K Huebner; C M Croce
Journal:  Br J Cancer       Date:  2003-05-19       Impact factor: 7.640

8.  Expression of Β-catenin and c-myc during human common bile duct development: a possible role in the morphogenesis of the common bile duct.

Authors:  W L Guo; Q Zhang; J Wang
Journal:  Braz J Med Biol Res       Date:  2014-05-30       Impact factor: 2.590

9.  Altered expression levels of occludin, claudin-1 and myosin light chain kinase in the common bile duct of pediatric patients with pancreaticobiliary maljunction.

Authors:  Shun-Gen Huang; Wan-Liang Guo; Zhi-Cheng Zhou; Jun-Jie Li; Fu-Bin Yang; Jian Wang
Journal:  BMC Gastroenterol       Date:  2016-01-16       Impact factor: 3.067

10.  Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel Biomarkers.

Authors:  Romina Briffa; Inhwa Um; Dana Faratian; Ying Zhou; Arran K Turnbull; Simon P Langdon; David J Harrison
Journal:  PLoS One       Date:  2015-12-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.